Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · IEX Real-Time Price · USD
7.54
-0.60 (-7.37%)
At close: Jul 2, 2024, 4:00 PM
7.56
+0.02 (0.27%)
After-hours: Jul 2, 2024, 7:57 PM EDT

Summit Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
105
Market Cap
5.29B USD

Revenue Chart

* The company reports in GBP currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20230--
Dec 31, 2022705.00K-1.10M-61.03%
Dec 31, 20211.81M949.00K110.35%
Dec 31, 2020860.00K--
Dec 31, 2019---
Jan 31, 201957.09M41.64M269.50%
Jan 31, 201815.45M12.57M436.46%
Jan 31, 20172.88M--
Jan 31, 20160--
Jan 31, 20150--
Jan 31, 20140--
Jan 31, 20130--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Organon & Co. 6.35B
DENTSPLY SIRONA 3.94B
R1 RCM 2.31B
Lantheus Holdings 1.37B
Tempus AI 562.02M
Doximity 475.42M
Glaukos 326.43M
Krystal Biotech 95.95M
Revenue Rankings